Vaughan Nelson Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Vaughan Nelson Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-803,000	Closed	-$57.6M	–	216
2022 Q2	$57.6M	Sell	803,000 -11,210	-1%	-$820K	0.78%	34
2022 Q1	$65.9M	Buy	814,210 +31,160	+4%	+$2.64M	0.75%	36
2021 Q4	$80.4M	Sell	783,050 -217,575	-22%	-$20.9M	0.82%	31
2021 Q3	$87.5M	Buy	1,000,625 +64,345	+7%	+$5.82M	0.89%	33
2021 Q2	$83.8M	Buy	+936,280	New	+$79.1M	0.85%	35
2017 Q2	–	Sell	-369,000	Closed	-$16.9M	–	209
2017 Q1	$16.9M	Sell	369,000 -119,100	-24%	-$5.93M	0.2%	143
2016 Q4	$25.7M	Buy	+488,100	New	+$23.6M	0.3%	138

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vaughan Nelson Investment Management's SYNH Position: Q3 2022 in Review

Vaughan Nelson Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 803,000 shares — an estimated $57.6M sold.

Vaughan Nelson Investment Management first reported a position in SYNH in Q4 2016 and held it in 7 quarters. The position peaked at $87.5M in Q3 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Vaughan Nelson Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Vaughan Nelson Investment Management sold 803,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $57.6M.
Vaughan Nelson Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 7 quarters.
Vaughan Nelson Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $87.5M in Q3 2021.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Vaughan Nelson Investment Management's 13F filing for Q3 2022, filed 4 Nov 2022.